| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |